Abstract. Regio-and stereoselective reductions of several diketones to afford enantiopure hydroxy ketones or diols were accomplished using isolated alcohol dehydrogenases (ADHs). Results could be rationalised taking into account different (promiscuous) substrate-binding modes in the active site of the enzyme. Furthermore, interesting natural cyclic diketones were also reduced with high regio-and stereoselectivity.
Introduction
For decades, synthetic organic chemists have devoted their efforts in developing new and versatile protecting-deprotecting strategies in order to selectively modify similar reacting moieties in the same molecule. Hence, considering the loss of the yields and the laborious separation techniques in multistep protocols, a different approach is always desired. Biocatalysis has become a powerful tool for highly stereo-and regioselective transformations due to the intrinsic chirality of enzymes. [1] In particular, biocatalysed regioselective transformations using hydrolases have widely been described in the bibliography, [1, 2] while using oxidoreductases have less frequently been performed.
It is well established that enantioenriched anti diols can be readily available through epoxide ring opening starting from the suitable oxirane. [3] On the other hand, syn diols can be obtained via osmium-catalysed oxidation of olefins, among other methods. [4] Enantioselective epoxide hydrolase-catalysed oxirane opening leads to the preparation of anti diols, [5] but the intrinsic handicap of the maximum 50% yield still remains. Aldolases have also been employed to afford syn-or anti-derivatives, although the reversibility of these processes appears as the main drawback. [6] However, the use of alcohol dehydrogenases (ADHs, also called ketoreductases or carbonyl reductases) applied to the synthesis of such important compounds has been scarcely developed. In the last few years, the use of purified or overexpressed ADHs have gained increasing relevance. [7] [8] [9] [10] [11] [12] [13] [14] The requirement of expensive nicotinamide cofactors [NAD(P)H] in those processes has slowed down their industrial applicability, although the use of several methodologies to recycle the cofactor have greatly improved the efficacy of these biotransformations. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In the particular case of the synthesis of enantiopure hydroxy ketones and/or diols starting from the corresponding diketones employing isolated ADHs, there are few examples available in the literature. [19] [20] [21] [22] [23] [24] [25] [26] In other cases plants or microorganisms are employed, [27] [28] [29] [30] [31] [32] frequently affording a mixture of stereo-and regioisomers due to the action of several enzymes with different and/or opposite selectivities. These derivatives are important building blocks of many natural compounds, [33, 34] such as pheromones [35, 36] or antitumor agents like discodermolide. [37] As a result, they are used as chiral precursors for fine chemicals in the flavour and fragrance-, agrochemical-, and pharmaceutical industry. [38] α-Hydroxy ketones (also called acyloins), constitute well-known derivatives for the synthesis of 1,2-amino alcohols through diastereoselective reductive amination. [39] Furthermore, short-chain diols can be employed as starting materials for chiral polymers [40] or as backbone for chiral ligands applied to asymmetric transition metal catalysis. [41] O Herein we present a stereo-and regioselective ADH-catalysed reduction of several diketones of interest ( Figure 1 ) with excellent ees and des, using internal recycling of cofactor ('substrate-coupled' approach). We will focus on the different substrate recognition modes in order to explain the experimental results obtained, and we will show for the first time the quasi-irreversible reduction concept [42] catalysed by ADHs applied to 1,2-and 1,3-diketones.
Results and Discussion
As a first step, several diketones ( Figure 1) were chosen as suitable substrates to be reduced by commercial ADHs. [43] Thus, 1,2-(1a-c), 1,3-(1d-e), and 1,4-diketones (1f) were firstly used in order to study the acceptance of the tested enzymes (Scheme 1 and Table 1 ). Lactobacillus brevis ADH (LBADH), [44] alcohol dehydrogenase from Rhodococcus ruber (ADH-'A'), [45] and ADH from Thermoanaerobacter sp. (ADH-T) [46] were selected as biocatalysts to perform the corresponding reductions using an excess of 2-propanol as hydrogen donor, through a 'substrate-coupled' or 'biocatalytic hydrogen transfer' approach. [14] The first enzyme shows a perfect anti-Prelog selectivity, this is, it catalyses the transfer of the hydride to the carbonyl moiety through its si face, while the second and third ADHs display an excellent Prelog profile. e.e. [%] [c]
e.e.
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Reaction conditions: the corresponding diketone (1a-f, 100 mM) was added to the 50 mM Tris.HCl buffer pH 7.5 with the corresponding cofactor (1 mM) and 2-propanol (5% v v -1 ). [b] Measured by GC.
[c] Calculated by chiral GC. [d] Less than 5% of a by-product was formed.
Scheme 2. Promiscuous binding-modes of diketones 1a-c and hydroxy ketones 2a-c in the active site of alcohol dehydrogenases: LBADH (binding-modes A and B); and ADH-'A' and ADH-T (binding-modes C and D).
As can be noted, these ADHs accepted all the tested substrates although showing different behaviour. Thus, with diketone 1a, LBADH mainly afforded enantiopure syn derivative 2R,3R-4a (entry 1), while ADH-'A' mainly provided enantiopure hydroxy ketone S-2a (entry 2) and ADH-T anti diol 2S,3R-4a (entry 3). For the other 1,2-diketones 1b and 1c, LBADH showed a high preference for the regio-and stereoselective reduction of the carbonyl moiety at position 2, providing R-2b-c and a small quantity of anti diols 2R,3S-4b-c (entries 4 and 7). Meanwhile, Prelog biocatalysts allowed to obtain enantiopure anti diols 2S,3R-4b and 2S,3R-4c (entries 6, 8, and 9). On the other hand, the reduction of diketone 1b with ADH-'A' afforded 49% of the enantiopure hydroxy ketone S-2b (entry 5).
Looking at these results, it was obvious that the substrate structure greatly influenced the ADHcatalysed reductions. For instance, LBADH mainly provided the unexpected syn diol 4a starting from diketone 1a, but when the substrate presented an additional methylene group in the alkyl chain (1b), hydroxy ketone 2b resulted in the main product and enantiopure anti diol 4b as minor product. Especially the formation of syn-4a was very remarkable since this enzyme has always been described as a perfect anti-Prelog enzyme. [44] These data can be explained on basis of the promiscuous substrate binding of 1,2-diketones at the active site of the enzyme (Scheme 2). Thus, these substrates possess two reactive positions, and therefore different binding-modes can be involved. For 1,2-diketones such as 1a-c, the carbonyl moiety at position 2 will be reduced following the standard fashion, that is, with the methyl group located in the small pocket and the ethylcarbonyl moiety in the big one. The conflict arises when ketone at position 3 is also reduced. Since location of the nicotinamide cofactor is well defined in the active site of ADHs, [47] the hydride attack will take place through the same side, but two possible substrate orientations can exist: i) a similar one as the previously described, locating the hydroxyethyl group into the small binding-site and the ethyl moiety into the bigger site, thus affording the corresponding anti diols 4a-c (Scheme 2, bindingmodes A and C), or ii) the opposite substrate-binding providing the syn derivatives (Scheme 2, bindingmodes B and D). Depending on the pockets size of the biocatalyst, one mode will be favoured at the expense of the second one, and therefore different regio-and stereoisomer ratios will be obtained.
From the obtained results, LBADH favoured the opposite disposition of hydroxy ketone 2a with regards to diketone 1a (Scheme 2, mode A), while for alcohols 2b-c a similar binding was preferred (Scheme 2, mode B). For 2b-c, since in the reverse binding-mode a propyl or a butyl moiety, respectively, should be located in the small pocket, this biocatalyst was not able to afford the corresponding syn diols. The hydroxyethyl group already seems to crowd the small pocket of this ADH due to the low conversions obtained (less than 10%) for 4b-c (Table 1, entries 4  and 7) . On the other hand, ADH-'A' and ADH-T always preferred a similar disposition for 1a-c and 2a-c placing the larger acyl chain into the bigger binding-site (Scheme 2, mode C), thus mainly affording the corresponding anti diols 4a-c. As larger the difference between the acyl chain and the hydroxyethyl moiety was, better the des favouring the anti derivatives were (Table 1 , compare entries 2-3 with 5-6 and 8-9).
A clearer scenario appeared when 1,3-or 1,4-diketones (1d-f) were subjected to the hydrogen transfer conditions (Table 1 , entries 10 to 16). ADHs showed perfect regio-and stereoselectivity achieving the reduction of the carbonyl moiety at position 2 to afford enantiopure R-2d-f (in the case of LBADH) or S-2d-f (in the case of ADH-'A' and ADH-T) alcohols. Diketone 1f was less well accepted, obtaining moderate (with LBADH) or good conversions (with both Prelog enzymes). In this case another by-product (less than 5%) was formed.
The selective modification of natural compounds in order to obtain novel derivatives with enhanced biological activities is a difficult task which organic chemists must often face. [48, 49] In our particular case, the natural product 6-acetyl-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one (1g) and the derivative 1-(5-acetyl-2-methoxyphenyl)-3-methylbut-2-en-1-one (1h) were also chosen as substrates to study the regioand stereoselectivity in the bioreduction processes catalysed by isolated ADHs ( Table 2 ). The former was isolated from Ophryosporus axilliflorus (Griseb.) Hieron (Asteraceae). These and other related compounds showed anti-inflammatory activity. [50] Previous reductions of diketone 1g using plants were reported. [27, 51] It remained clear that LBADH was not a suitable enzyme to perform these bioreductions due to low conversions (entries 1 and 4). This is in concordance with the small active site of this biocatalyst. On the contrary, ADH-'A' and ADH-T were able to regioselectively reduce both substrates on the acetyl moiety (C a ) affording highly pure (S)-2g and 2h alcohols (entries 2, 3, 5 and 6). Until this point, we were pleased to find out that different kind of diketones could regio-and stereoselectively be reduced by the tested ADHs. Having in mind the scale-up of these processes, we tried to perform the bioreductions at lower cosubstrate concentration, using less harmful conditions for the biocatalyst and maximising the atom efficiency [52] of the process. We envisaged the possible irreversibility in the reduction of 1,2-and 1,3-diketones since it has previously been described that 1-chloro-2-propanol [42] cannot be oxidised by ADHs due to an intramolecular H-bond interaction between the hydroxyl group and the halogen atom. [53] Thus, 1,2-or 1,3-diketones could quasi-irreversibly be reduced since it is well known that the corresponding hydroxy ketones show a strong intramolecular interaction via H-bonding network (Figure 2 ). In order to demonstrate this fact, [55] we repeated the LBADH catalysed reduction of diketones 1b, 1d, and 1e employing different concentrations of 2-propanol (from 2 equiv. to 10 equiv.), and results were compared with that obtained in the case of a non-activated ketone such as 2-octanone (1i). As can be noticed (Table 3) , diketones were reduced into the corresponding hydroxy ketones (c >90%) even at low 2-propanol concentration (entries 1, 4 and 7). On the contrary, for ketone 1i (entry 10) conversion was 67% due to the similar equilibrium constants between the 2-octanone/2-octanol and acetone/2-propanol pairs.
[56] Table 3 . LBADH-catalysed reduction of 1,2-(1b), 1,3-diketones (1d-e) and 2-octanone (1i), using different concentrations of 2-propanol. Reaction conditions: the corresponding diketone (100 mM) was added to the 50 mM Tris.HCl buffer pH 7.5 with the corresponding cofactor (1 mM) and 2-propanol (200 mM-1M).
[b] Measured by GC.
Since a small amount of 2-propanol (2 equiv.) can be employed to quantitatively reduce this type of substrates, enantiopure (R)-alcohols 2b, 2d, and 2e were prepared on a higher scale starting from 25 mg of the corresponding diketones with isolated yields higher than 80%.
Conclusions
The bioreduction of diketones has not been extensively studied, [19] [20] [21] [22] [23] [24] [25] [26] and in several cases microorganisms or plants [27] [28] [29] [30] [31] [32] were used for this purpose. Thus, the obtained results in terms of regioand stereoselectivity usually remained unclear. Herein we have shown the bioreduction of several diketones of interest catalysed by isolated alcohol dehydrogenases. With the advantage of using a single enzyme, we have proposed that in reductions of 1,2-diketones, these substrates can be suited within the active site of the enzyme in two different orientations depending on the size of the enzyme pockets. Hence, just by choosing the proper catalyst, syn or anti products could be obtained. For instance, due to its small binding-site, LBADH presents a promiscuous binding for the diketone 1a and the hydroxy ketone intermediate to afford the corresponding syn-diol. On the other hand, ADH-'A' and ADH-T favour a similar recognition mode for both species, thus mainly providing the anti-derivatives. This is an elegant example of enzyme-based stereocontrol. [57] In the case of the other diketones studied, perfect regioand stereoselectivity was achieved obtaining the corresponding enantiopure hydroxy ketones.
In addition, it has been demonstrated that 1,2-or 1,3-diketones can be reduced via ADH-catalysed hydrogen transfer using quasi-irreversible conditions, [42] this is, employing a low excess of the required co-substrate (2-propanol). This is due to the difficulty of the enzyme to oxidise backwards the formed hydroxy ketone due to an intramolecular Hbond interaction between the hydroxyl and the remaining carbonyl moiety. Since a lower amount of the hydrogen donor (usually used in a huge excess) is needed, the scale-up of the ADH-catalysed reductions of such compounds is feasible.
Experimental Section
General. Alcohol dehydrogenases and ketones 1a-1f, 1i were purchased from commercial sources. Ketone 1g was isolated from aerial parts of Ophryosporus axilliflorus (Griseb.) Hieron according to Favier et al. [50] The same procedure also afforded the diketone 1-(5-acetyl-2-hydroxyphenyl)-3-methylbut-2-en-1-one which was methylated by classical methods (Me 2 SO 4 , K 2 CO 3 , under acetone reflux, 2 h) to obtain 1h. Racemic alcohols 2a-h, 3a-c and 4a-c were purchased or synthesised by conventional reduction from the corresponding ketones (NaBH 4 , MeOH, 0 ºC or room temperature). All other reagents and solvents were of the highest quality available. 1 unit (U) of ADH reduces 1.0 μM of acetophenone to 1-phenylethanol per minute at pH 7.5 and 30 ºC in the presence of NAD(P)H. Flash chromatography was performed using silica gel 60 (230-400 mesh).
General protocol for the biocatalytic reduction of diketones employing ADHs and 2-propanol. In a 1.5 mL Eppendorf vial, 3 U of ADH (Lactobacillus brevis ADH, Rhodococcus ruber ADH-'A', or Thermoanaerobacter sp. ADH) in Tris.HCl buffer [50 mM, pH 7.5, 1 mM NAD(P)H, 1 mM MgCl 2 for LB-ADH] were mixed with 2-propanol (32 µL, 5% v v -1 ) and the corresponding diketone (1a-1f, and 1i, 100 mM; 1g-1h, 50 mM). Reactions were shaken at 30 ºC and 120 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 0.5 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried (Na 2 SO 4 ). Conversions and enantiomeric excesses of the corresponding alcohols were determined by GC or HPLC analysis on an achiral or a chiral stationary phase, respectively (see Supporting Information).
General protocol for the biocatalytic reduction of diketones employing LBADH with different concentrations of 2-propanol. In a 1.5 mL Eppendorf vial, 3 U of LBADH in Tris.HCl buffer (50 mM, pH 7.5, 1 mM NADPH, 1 mM MgCl 2 ) were mixed with 2-propanol (200 mM-1 M) and the corresponding diketone (1b, 1d, 1e or 1i , 100 mM). Reactions were shaken at 30 ºC and 120 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 0.5 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried (Na 2 SO 4 ). Conversions were determined by GC analysis on an achiral stationary phase (see Supporting Information). 
